160 related articles for article (PubMed ID: 25139203)
1. Antiretroviral therapy initiation in an Australian cohort: implications for increased use of antiretroviral therapy.
Stratov I; Kent SJ
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):253-9. PubMed ID: 25139203
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
[TBL] [Abstract][Full Text] [Related]
3. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
Bouteloup V; Sabin C; Mocroft A; Gras L; Pantazis N; Le Moing V; d'Arminio Monforte A; Mary-Krause M; Roca B; Miro JM; Battegay M; Brockmeyer N; Berenguer J; Morlat P; Obel N; De Wit S; Fätkenheuer G; Zangerle R; Ghosn J; Pérez-Hoyos S; Campbell M; Prins M; Chêne G; Meyer L; Dorrucci M; Torti C; Thiébaut R;
HIV Med; 2017 Jan; 18(1):33-44. PubMed ID: 27625009
[TBL] [Abstract][Full Text] [Related]
4. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
[TBL] [Abstract][Full Text] [Related]
5. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
[TBL] [Abstract][Full Text] [Related]
6. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J;
AIDS; 2015 Nov; 29(17):2323-33. PubMed ID: 26544704
[TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.
Rajasuriar R; Gouillou M; Spelman T; Read T; Hoy J; Law M; Cameron PU; Petoumenos K; Lewin SR
PLoS One; 2011; 6(6):e20713. PubMed ID: 21674057
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda.
Sempa J; Ssennono M; Kuznik A; Lamorde M; Sowinski S; Semeere A; Hermans S; Castelnuovo B; Manabe YC
BMC Public Health; 2012 Sep; 12():736. PubMed ID: 22943068
[TBL] [Abstract][Full Text] [Related]
9. Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.
Jose S; Quinn K; Dunn D; Cox A; Sabin C; Fidler S;
HIV Med; 2016 May; 17(5):368-72. PubMed ID: 26306942
[TBL] [Abstract][Full Text] [Related]
10. Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience.
Wright ST; Petoumenos K; Boyd M; Carr A; Downing S; O'Connor CC; Grotowski M; Law MG;
HIV Med; 2013 Apr; 14(4):208-16. PubMed ID: 23036045
[TBL] [Abstract][Full Text] [Related]
11. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.
IeDEA and COHERE Cohort Collaborations
Clin Infect Dis; 2018 Mar; 66(6):893-903. PubMed ID: 29373672
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
[TBL] [Abstract][Full Text] [Related]
13. European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.
Guzmán-Fulgencio M; Berenguer J; Micheloud D; Fernández-Rodríguez A; García-Álvarez M; Jiménez-Sousa MA; Bellón JM; Campos Y; Cosín J; Aldámiz-Echevarría T; Catalán P; López JC; Resino S
J Antimicrob Chemother; 2013 Oct; 68(10):2349-57. PubMed ID: 23749950
[TBL] [Abstract][Full Text] [Related]
14. Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.
Pantazis N; Papastamopoulos V; Paparizos V; Metallidis S; Adamis G; Antoniadou A; Psichogiou M; Chini M; Sambatakou H; Sipsas NV; Gogos C; Chrysos G; Panagopoulos P; Katsarou O; Gikas A; Touloumi G;
AIDS; 2019 Aug; 33(10):1645-1655. PubMed ID: 31305332
[TBL] [Abstract][Full Text] [Related]
15. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.
Bohlius J; Schmidlin K; Boué F; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Paparizos V; Miro JM; Obel N; Prins M; Chêne G; Egger M;
Blood; 2011 Jun; 117(23):6100-8. PubMed ID: 21368291
[TBL] [Abstract][Full Text] [Related]
17. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
18. Recent trends in early stage response to combination antiretroviral therapy in Australia.
McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG;
Antivir Ther; 2015; 20(2):131-9. PubMed ID: 24704818
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in interleukin-7 receptor α gene is associated with faster CD4⁺ T-cell recovery after initiation of combination antiretroviral therapy.
Hartling HJ; Thørner LW; Erikstrup C; Harritshøj LH; Kronborg G; Pedersen C; Larsen CS; Helleberg M; Gerstoft J; Obel N; Ullum H; Nielsen SD
AIDS; 2014 Jul; 28(12):1739-48. PubMed ID: 24911352
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]